MedTrace Logo

Growth of Infants Fed New Starter Formula

NCT01079208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 297

Last updated 2014-12-03

No results posted yet for this study

Summary

The purpose of this study is to assess the growth of infants fed a novel starter formula containing synbiotics and different protein levels, compared to a standard starter infant formula, during the first four months of life.

Conditions

  • Dietary Intervention

Interventions

OTHER

test starter infant formula

infants are fed for 6 months with this starter formula

OTHER

test starter infant formula with synbiotics

infant are fed for 6 months with this formula

OTHER

control standard formula

infant are fed 6 months with this formula

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Michael Cabana, MD, MPH · Institute for Health Policy Studies, University of California

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
11 Days
Max Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-12-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01079208 on ClinicalTrials.gov